BRAIN Biotech AG Ratios and Metrics

Market cap in millions EUR. Fiscal year is October - September.

Millions EUR. Fiscal year is Oct - Sep.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	2020 - 2016
Period Ending	Mar '26 Mar 9, 2026	Sep '25 Sep 30, 2025	Sep '24 Sep 30, 2024	Sep '23 Sep 30, 2023	Sep '22 Sep 30, 2022	Sep '21 Sep 30, 2021	2020 - 2016
Market Capitalization	51	48	46	93	96	221	Upgrade
Market Cap Growth	-19.31%	2.83%	-50.00%	-3.85%	-56.34%	56.48%	Upgrade
Enterprise Value	46	37	35	89	83	213	Upgrade
Last Close Price	2.34	2.18	2.12	4.24	4.41	10.10	Upgrade
PS Ratio	1.04	0.95	0.84	1.65	1.92	5.63	Upgrade
PB Ratio	-70.22	25.89	3.34	4.03	2.81	5.28	Upgrade
P/TBV Ratio	-	-	-	14.13	7.48	8.74	Upgrade
EV/Sales Ratio	0.94	0.74	0.62	1.58	1.65	5.44	Upgrade
Debt / Equity Ratio	-	11.27	1.89	0.45	0.31	0.27	Upgrade
Net Debt / Equity Ratio	7.07	7.84	-0.07	0.22	0.07	-0.32	Upgrade
Net Debt / EBITDA Ratio	1.44	-3.31	0.16	-2.11	-0.68	3.23	Upgrade
Net Debt / FCF Ratio	0.54	-1.34	0.18	-0.74	-0.30	2.56	Upgrade
Asset Turnover	0.67	0.65	0.70	0.76	0.65	0.52	Upgrade
Inventory Turnover	-	2.41	2.60	2.66	2.72	2.49	Upgrade
Quick Ratio	0.29	0.86	1.41	0.87	0.93	2.78	Upgrade
Current Ratio	1.48	1.42	1.83	1.46	1.42	3.45	Upgrade
Return on Equity (ROE)	-223.66%	-150.49%	-60.16%	-28.34%	-16.67%	-13.77%	Upgrade
Return on Assets (ROA)	-5.92%	-6.25%	-7.06%	-4.67%	-5.12%	-6.16%	Upgrade
Return on Capital Employed (ROCE)	-14.20%	-15.90%	-14.10%	-10.40%	-11.30%	-11.10%	Upgrade
Earnings Yield	-20.78%	-24.65%	-24.02%	-8.94%	-6.84%	-2.25%	Upgrade
FCF Yield	-18.56%	-22.60%	-11.09%	-7.38%	-7.56%	-2.34%	Upgrade
Buyback Yield / Dilution	-	-	-	-	-9.55%	-6.89%	Upgrade

Source: S&P Capital IQ. Standard template. Financial Sources.